Factors responsible for poor sleep quality in patients with chronic obstructive pulmonary disease

[1]  L. Hang,et al.  COPD in Taiwan: a National Epidemiology Survey , 2015, International journal of chronic obstructive pulmonary disease.

[2]  B. Panchal,et al.  Association of psychiatric co-morbidities and quality of life with severity of chronic obstructive pulmonary disease. , 2014, East Asian archives of psychiatry : official journal of the Hong Kong College of Psychiatrists = Dong Ya jing shen ke xue zhi : Xianggang jing shen ke yi xue yuan qi kan.

[3]  Maurice M Ohayon,et al.  Chronic Obstructive Pulmonary Disease and its association with sleep and mental disorders in the general population. , 2014, Journal of psychiatric research.

[4]  D. Price,et al.  Impact of night-time symptoms in COPD: a real-world study in five European countries , 2013, International journal of chronic obstructive pulmonary disease.

[5]  W. McNicholas,et al.  Sleep disorders in COPD: the forgotten dimension , 2013, European Respiratory Review.

[6]  D. Rapoport,et al.  Nocturia, sleep and daytime function in stable heart failure. , 2012, Journal of cardiac failure.

[7]  T. Omachi,et al.  Disturbed sleep among COPD patients is longitudinally associated with mortality and adverse COPD outcomes. , 2012, Sleep medicine.

[8]  K. Yoshimura.  Correlates for nocturia: A review of epidemiological studies , 2012, International journal of urology : official journal of the Japanese Urological Association.

[9]  M. Cazzola,et al.  Night-time symptoms: a forgotten dimension of COPD , 2011, European Respiratory Review.

[10]  P. Austin,et al.  Inhaled anticholinergic drug therapy and the risk of acute urinary retention in chronic obstructive pulmonary disease: a population-based study. , 2011, Archives of internal medicine.

[11]  A. Pickard,et al.  Comparison of health-related quality of life measures in chronic obstructive pulmonary disease , 2011, Health and quality of life outcomes.

[12]  P. Lavie,et al.  Sleep profile and symptoms of sleep disorders in patients with stable mild to moderate chronic obstructive pulmonary disease. , 2011, Sleep medicine.

[13]  H. Reuveni,et al.  International Journal of Chronic Obstructive Pulmonary Disease Dovepress Sleep Quality Predicts Quality of Life in Chronic Obstructive Pulmonary Disease , 2022 .

[14]  P. Jones,et al.  Development and first validation of the COPD Assessment Test , 2009, European Respiratory Journal.

[15]  V. Bruin,et al.  Impaired Sleep Reduces Quality of Life in Chronic Obstructive Pulmonary Disease , 2009, Lung.

[16]  P. Bruin,et al.  Impaired Sleep Reduces Quality of Life in Chronic Obstructive Pulmonary Disease. , 2009, ATS 2009.

[17]  K. Chida,et al.  Tiotropium does not affect lower urinary tract functions in COPD patients with benign prostatic hyperplasia. , 2008, Pulmonary pharmacology & therapeutics.

[18]  I. Zeng,et al.  Isolated nocturnal desaturation in COPD: prevalence and impact on quality of life and sleep , 2008, Thorax.

[19]  Bartolome Celli,et al.  Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. , 2007, The New England journal of medicine.

[20]  T. Tammela,et al.  Incidence of nocturia in 50 to 80-year-old Finnish men. , 2006, The Journal of urology.

[21]  Chun-Jen Huang,et al.  Psychometric Evaluation of the Chinese Version of the Pittsburgh Sleep Quality Index (CPSQI) in Primary Insomnia and Control Subjects , 2005, Quality of Life Research.

[22]  David M. Shade,et al.  Sleep Quality in Asthma: Results of a Large Prospective Clinical Trial , 2004, The Journal of asthma : official journal of the Association for the Care of Asthma.

[23]  W. McNicholas,et al.  Long-acting inhaled anticholinergic therapy improves sleeping oxygen saturation in COPD , 2004, European Respiratory Journal.

[24]  D. Hudgel,et al.  Effect of ipratropium bromide treatment on oxygen saturation and sleep quality in COPD. , 1999, Chest.

[25]  S. Wenzel,et al.  The effect of salmeterol on nocturnal symptoms, airway function, and inflammation in asthma. , 1997, Chest.

[26]  B. Phillips,et al.  Effects of dexamethasone on sleep. , 1996, Pharmacology & toxicology.

[27]  W. McNicholas,et al.  Ventilation and gas exchange during sleep and exercise in severe COPD. , 1996, Chest.

[28]  T. Roth,et al.  Effects of theophylline on nocturnal sleep and daytime sleepiness/alertness. , 1995, Chest.

[29]  P. Barnes,et al.  Inhaled glucocorticoids for asthma. , 1995, The New England journal of medicine.

[30]  R. Beck,et al.  Side effects of glucocorticoid treatment. Experience of the Optic Neuritis Treatment Trial. , 1993, JAMA.

[31]  N. Douglas,et al.  Salmeterol in nocturnal asthma: a double blind, placebo controlled trial of a long acting inhaled beta 2 agonist. , 1990, BMJ.

[32]  Daniel J Buysse,et al.  The Pittsburgh sleep quality index: A new instrument for psychiatric practice and research , 1989, Psychiatry Research.

[33]  C K Wells,et al.  Evaluation of clinical methods for rating dyspnea. , 1988, Chest.

[34]  S. Quan,et al.  Prevalence of reported sleep disturbances in a general adult population and their relationship to obstructive airways diseases. , 1987, Chest.

[35]  J. Fleetham,et al.  Sleep, arousals, and oxygen desaturation in chronic obstructive pulmonary disease. The effect of oxygen therapy. , 1982, The American review of respiratory disease.

[36]  F. Martinez,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. , 2007, American journal of respiratory and critical care medicine.

[37]  J. Samet,et al.  Sleep and sleep-disordered breathing in adults with predominantly mild obstructive airway disease. , 2003, American journal of respiratory and critical care medicine.

[38]  R. Ballard,et al.  Influence of sleep on respiratory function in emphysema. , 1995, American journal of respiratory and critical care medicine.

[39]  S. Quan,et al.  The relation of sleep complaints to respiratory symptoms in a general population. , 1994, Chest.